Determining homogeneity of clinical controls
AssigneeBaxter Laboratories, Inc.
InventorsAllan L. Louderback, Anthony J. Fontana
Life of this patent
Estimating the term…
Abstract
Homogeneity of bulk control serum is determined when making production fills of clinical chemistry control serum using a radioactive tracer in the bulk control serum tank. A radioactive tracer is added to the control serum along with any other added constituents. After standard bottles are filled, they are analyzed for radioactivity in a radiation counter for measuring the amount of radioactive tracer in each bottle and thereby determining the homogeneity of the contents of the bottles.
Claims3
A method of determining homogeneity of clinical control serum comprising adding batchwise to the bulk control serum a radioactive tracer having a halflife of from about 4 days to about 15 days, filling standard containers with the control serum containing the radioactive tracer, analyzing said filled standard containers in a radiation counter to determine the amount of radioactivity present in said containers and comparing the inter-container differences in said radioactivity.
Dependencies are inferred from the claim text.